−70.0
Enanta Pharmaceuticals, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
−84.8
FY23:
−103
FY24:
−78.8
FY25:
−19.3
Change from FY21 to FY25
millions USD
FY21:
37.0
FY22:
54.9
FY23:
−53.6
FY24:
58.2
FY25:
40.3
Change from FY21 to FY25
millions USD
FY21:
3.08
FY22:
20.0
FY23:
198
FY24:
−27.6
FY25:
−26.6
millions USD
FY21:
−29.9
FY22:
−9.85
FY23:
41.4
FY24:
−48.2
FY25:
−5.54
(positive)
Change from FY21 to FY25
millions USD
FY21:
−70.7
FY22:
−86.9
FY23:
−112
FY24:
−96.7
FY25:
−32.2
All amounts in millions USD